Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE).

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Clinical Investigation

• Publication date

  2001-12-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1172/JCI11951PMID 11748269PMCID PMC209461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro.

  2001cited by this paper
• Renoprotective effects of a novel inhibitor of advanced glycation

  2001cited by this paper
• An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.

  2000cited by this paper
• Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy

  2000cited by this paper
• Transforming growth factor β contributes to progressive diabetic nephropathy

  2000cited by this paper
• The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation

  2000influential reference
• Transforming growth factor beta contributes to progressive diabetic nephropathy.

  2000cited by this paper
• Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.

  2000cited by this paper
• Transdifferentiation comes of age.

  2000cited by this paper
• Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195

  1999cited by this paper
• Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro.

  1999influential reference
• N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression*

  1999influential reference
• Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding.

  1999cited by this paper
• Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats.

  1998cited by this paper
• Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

  1998influential reference
• Renal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic rats1

  1998cited by this paper
• Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats.

  1998cited by this paper
• The quantification of protein amino groups by the trinitrobenzenesulfonic acid method: a reexamination.

  1997cited by this paper
• The Receptor for Advanced Glycation End Products Mediates the Chemotaxis of Rabbit Smooth Muscle Cells

  1997cited by this paper
• Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury

  1997influential reference
• Myofibroblasts and arteriolar sclerosis in human diabetic nephropathy.

  1997cited by this paper
• An agent cleaving glucose-derived protein crosslinks in vitro and in vivo.

  1996cited by this paper
• An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

  1996cited by this paper
• Induction of TGF-beta 1 synthesis in D-glucose primed human proximal tubular cells by IL-1 beta and TNF alpha.

  1996cited by this paper
• Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells

  1996cited by this paper
• Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment.

  1996cited by this paper
• Expression of transforming growth factor-beta isoforms in human glomerular diseases.

  1996cited by this paper
• New York, New York, USA

  1996cited by this paper
• Induction of TGF-β1 synthesis in D-glucose primed human proximal tubular cells by IL-1β and TNFα

  1996cited by this paper
• Expression of transforming growth factor-β isoforms in human glomerular diseases

  1996cited by this paper
• Expression of receptors for advanced glycosylated end-products in renal disease.

  1995cited by this paper
• Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation–modified proteins to a conserved motif

  1995cited by this paper
• Identification of Galectin-3 As a High-Affinity Binding Protein for Advanced Glycation End Products (AGE): A New Member of the AGE-Receptor Complex

  1995cited by this paper
• PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products.

  1995cited by this paper
• [The renal tubulointerstitium in diabetes mellitus].

  1995cited by this paper
• Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease.

  1995cited by this paper
• Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors.

  1994cited by this paper
• Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.

  1994cited by this paper
• Clinical and Histological Correlations of Decline in Renal Function in Diabetic Patients With Proteinuria

  1994cited by this paper
• Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.

  1994cited by this paper
• Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury.

  1994cited by this paper
• The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide.

  1994cited by this paper
• Myofibroblasts, predictors of progression of mesangial IgA nephropathy?

  1994cited by this paper
• Myofibroblast-like cells produce mRNA for type I and III procollagens in chronic active hepatitis.

  1993cited by this paper
• Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.

  1993influential reference
• Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts

  1993cited by this paper
• Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface.

  1992cited by this paper
• Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.

  1992cited by this paper
• Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins

  1991cited by this paper
• The renal tubulointerstitium in diabetes mellitus.

  1991cited by this paper
• Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy

  1991cited by this paper
• Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat

  1991cited by this paper
• Handbook of Biological Confocal Microscopy

  1990cited by this paper
• Effects of genetic hypertension on diabetic nephropathy in the rat--functional and structural characteristics.

  1988cited by this paper
• Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling.

  1988cited by this paper
• High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules.

  1985cited by this paper
• Nonenzymatic glycosylation and the pathogenesis of diabetic complications.

  1984cited by this paper
• LIGAND: a computerized analysis of ligand binding data.

  1983cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

  1963cited by this paper

• ZBP1 Mediates Renal Tubular Injury in Diabetic Nephropathy Through RIPK3-mediated Necroptosis

  2026cites this paper
• Spinach Extract Reduces Kidney Damage in Diabetic Rats by Impairing the AGEs/RAGE Axis

  2025cites this paper
• Advanced Glycation End Products Mediate Epigenetic Alteration of H3K27me3 in Renal Proximal Tubular Cells: Potential Role in Metabolic Memory

  2025cites this paper
• Targeting advanced glycation end products: potential therapeutic approaches for mitigating diabetic intervertebral disc degeneration?

  2025cites this paper
• Role of Nuclear Receptors, Lipid Metabolism, and Mitochondrial Function in the Pathogenesis of Diabetic Kidney Disease.

  2025cites this paper
• Anemia in diabetes mellitus: Pathogenetic aspects and the value of early erythropoietin therapy

  2025cites this paper
• The Potential Role of Advanced Glycation End Products in the Development of Kidney Disease

  2025cites this paper
• Tubular Injury in Diabetic Kidney Disease: Early Diagnosis and Intervention Strategies

  2025cites this paper
• The roles of advanced glycation end products in cardiovascular diseases: from mechanisms to therapeutic strategies

  2025cites this paper
• Ursodeoxycholic acid ameliorates erectile dysfunction and corporal fibrosis in diabetic rats by inhibiting the TGF-β1/Smad2 pathway

  2024cites this paper
• Handling the sugar rush: The role of the renal proximal tubule.

  2024cites this paper
• Aberrant splicing of CaV1.2 calcium channel induced by decreased Rbfox1 enhances arterial constriction during diabetic hyperglycemia

  2024cites this paper
• Long-term effects of warm water immersion on kidney tissue damage in diabetic rats

  2024cites this paper
• Non-enzymatic glycation and diabetic kidney disease.

  2024cites this paper
• Exploring unconventional targets in myofibroblast transdifferentiation outside classical TGF- β signaling in renal fibrosis

  2024cites this paper
• Molecular Basis for the Involvement of Mammalian Serum Albumin in the AGE/RAGE Axis: A Comprehensive Computational Study

  2024cites this paper
• Advanced glycation end products (AGEs) impair the intestinal epithelial barrier via STAT3 activation mediated by macrophages.

  2024cites this paper
• The impact of diabetes mellitus on blood-tissue barrier regulation and vascular complications: Is the lung different from other organs?

  2024cites this paper
• An anti-RAGE chimeric antibody alleviates CCl4-induced liver fibrosis via RAGE/NF-kB pathway in mice.

  2024cites this paper
• Sanziguben Polysaccharides Attenuate Renal Epithelial‐Mesenchymal Transition in Diabetic Nephropathy through Nrf2‐Mediated Regulation of TGF‐β1/Smad7 Signaling Pathway

  2024cites this paper
• Effect of advanced glycation end-products in a wide range of medical problems including COVID-19.

  2024cites this paper
• Ferroptosis Mediates the Progression of Hyperuricemic Nephropathy by Activating RAGE Signaling

  2024cites this paper
• Nε-Carboxymethyl-Lysine Modification of Extracellular Matrix Proteins Augments Fibroblast Activation

  2023cites this paper
• RAGE pathways play an important role in regulation of organ fibrosis.

  2023cites this paper
• The role of immunosuppressive myofibroblasts in the aging process and age-related diseases

  2023cites this paper
• The Mechanism of Hyperglycemia-Induced Renal Cell Injury in Diabetic Nephropathy Disease: An Update

  2023cites this paper
• The plasticity of fibroblasts: A forgotten player in the aging process.

  2023cites this paper
• AVALIAÇÃO MORFOLÓGICA DO CÓLON PROXIMAL DE RATOS DIABÉTICOS SUPLEMENTADOS COM EXTRATO DE AGARICUS BLAZEI MURRILL

  2023cites this paper
• Receptor for advanced glycation end-products: Biological significance and imaging applications.

  2023cites this paper
• The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy: From Pathophysiology to Clinical Diagnostic Tools

  2023cites this paper
• Pathomechanisms of Diabetic Kidney Disease

  2023cites this paper
• AMPK signaling inhibits the differentiation of myofibroblasts: impact on age-related tissue fibrosis and degeneration

  2023cites this paper
• The Beneficial Effects of Chinese Herbal Monomers on Ameliorating Diabetic Cardiomyopathy via Nrf2 Signaling

  2022cites this paper
• Receptor of Advanced Glycation End Products Deficiency Attenuates Cisplatin-Induced Acute Nephrotoxicity by Inhibiting Apoptosis, Inflammation and Restoring Fatty Acid Oxidation

  2022cites this paper
• Salivary Glycopatterns as Potential Non-Invasive Biomarkers for Diagnosing and Reflecting Severity and Prognosis of Diabetic Nephropathy

  2022cites this paper
• Rap1a Activity Elevated the Impact of Endogenous AGEs in Diabetic Collagen to Stimulate Increased Myofibroblast Transition and Oxidative Stress

  2022cites this paper
• Glucosidase inhibitor, Nimbidiol ameliorates renal fibrosis and dysfunction in type-1 diabetes

  2022cites this paper
• Renal insufficiency and chronic kidney disease - Promotor or consequence of pathological post-translational modifications.

  2022cites this paper
• Mitochondrial Pathophysiology on Chronic Kidney Disease

  2022cites this paper
• Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-sensitive Pathways.

  2022cites this paper
• Activation of Transcription Factor EB Alleviates Tubular Epithelial Cell Injury via Restoring Lysosomal Homeostasis in Diabetic Nephropathy

  2022cites this paper
• Inhibition of S100A8/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy.

  2022cites this paper
• Fibrous stroma: Driver and passenger in cancer development

  2022cites this paper
• İleri Glikasyon Son Ürünlerinin Diyabet Komplikasyonları Üzerine Etkileri: Bir Derleme

  2022cites this paper
• Effect of Costus pictus per se and in combination with Metformin and Enalapril in streptozotocin induced diabetic nephropathy in rats

  2022cites this paper
• Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases

  2022cites this paper
• RAGE pathway activation and function in chronic kidney disease and COVID-19

  2022influential citation
• The Pathophysiological Basis of Diabetic Kidney Protection by Inhibition of SGLT2 and SGLT1.

  2022cites this paper
• Glycolaldehyde induces synergistic effects on vascular inflammation in TNF-α-stimulated vascular smooth muscle cells

  2022cites this paper
• Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?

  2022cites this paper
• Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-β) and related molecules

  2022cites this paper
• Transforming growth factor-β2-mediated mesenchymal transition in lens epithelial cells is repressed in the absence of RAGE.

  2021cites this paper
• Signaling Pathways Involved in Diabetic Renal Fibrosis

  2021cites this paper
• The receptor for advanced glycation endproducts (RAGE) decreases survival of tumor-bearing mice by enhancing the generation of lung metastasis-associated myeloid-derived suppressor cells.

  2021cites this paper
• Rap1a Overlaps the AGE/RAGE Signaling Cascade to Alter Expression of α-SMA, p-NF-κB, and p-PKC-ζ in Cardiac Fibroblasts Isolated from Type 2 Diabetic Mice

  2021cites this paper
• The 100 top-cited articles in diabetic kidney disease: a bibliometric analysis

  2021cites this paper
• Integrative Role of Albumin: Evolutionary, Biochemical and Pathophysiological Aspects

  2021cites this paper
• Rap1a Regulates Cardiac Fibroblast Contraction of 3D Diabetic Collagen Matrices by Increased Activation of the AGE/RAGE Cascade

  2021cites this paper
• Phosphate and fibroblast growth factor 23 in diabetes

  2021cites this paper
• Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences

  2021cites this paper
• Methylglyoxal-Derived Advanced Glycation End Products (AGE4) Promote Cell Proliferation and Survival in Renal Cell Carcinoma Cells through the RAGE/Akt/ERK Signaling Pathways.

  2021cites this paper
• Collagen Biosynthesis, Processing, and Maturation in Lung Ageing

  2021cites this paper
• Epigenetic Histone Modifications in the Pathogenesis of Diabetic Kidney Disease

  2021cites this paper
• Роль конечных продуктов гликирования в развитии и прогрессировании диабетической нейроостеоартропатии

  2021cites this paper
• Serum Albumin in Health and Disease: Esterase, Antioxidant, Transporting and Signaling Properties

  2021cites this paper
• Association of Novel Advanced Glycation End-Product (AGE10) with Complications of Diabetes as Measured by Enzyme-Linked Immunosorbent Assay

  2021cites this paper
• The Aggressive Diabetic Kidney Disease in Youth-Onset Type 2 Diabetes: Pathogenetic Mechanisms and Potential Therapies

  2021cites this paper
• Glyoxal-Lysine Dimer, an Advanced Glycation End Product, Induces Oxidative Damage and Inflammatory Response by Interacting with RAGE

  2021cites this paper
• Dysregulation of gastrointestinal RAGE (receptor for advanced glycation end products) expression in dogs with chronic inflammatory enteropathy.

  2021cites this paper
• Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosis.

  2021cites this paper
• Hyperglycemic memory in diabetic cardiomyopathy

  2021cites this paper
• Fibrosis of the diabetic heart: clinical significance, molecular mechanisms, and therapeutic opportunities.

  2021cites this paper
• A Catecholaldehyde Metabolite of Norepinephrine Induces Myofibroblast Activation and Toxicity via the Receptor for Advanced Glycation Endproducts: Mitigating Role of l-Carnosine

  2021cites this paper
• Hispidulin modulates epithelial-mesenchymal transition in breast cancer cells

  2020cites this paper
• Diabetic fibrosis.

  2020cites this paper
• Diabetes and cardiovascular disease: inter-relation of risk factors and treatment

  2020cites this paper
• Dietary Advanced Glycation Endproducts and the Gastrointestinal Tract

  2020cites this paper
• Schistosoma japonicum SjE16.7 Protein Promotes Tumor Development via the Receptor for Advanced Glycation End Products (RAGE)

  2020cites this paper
• ADVANCED GLYCATED END PRODUCTS (AGES) IN DIABETES AND ITS COMPLICATIONS: AN INSIGHT

  2020cites this paper
• Metabolic reprogramming by N‐acetyl‐seryl‐aspartyl‐lysyl‐proline protects against diabetic kidney disease

  2020cites this paper
• Plasma High Mobility Group Box 1 (HMGB1), Osteopontin (OPN), and Hyaluronic Acid (HA) as Admissible Biomarkers for Endometriosis

  2019cites this paper
• Dapagliflozin Attenuates Renal Tubulointerstitial Fibrosis Associated With Type 1 Diabetes by Regulating STAT1/TGFβ1 Signaling

  2019cites this paper
• A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE

  2019cites this paper
• Aminoguanidine reduces diabetes-associated cardiac fibrosis.

  2019cites this paper
• Extracellular matrix components isolated from diabetic mice alters cardiac fibroblast function through the AGE/RAGE signaling cascade

  2019cites this paper
• The Modern Western Diet Rich in Advanced Glycation End-Products (AGEs): An Overview of Its Impact on Obesity and Early Progression of Renal Pathology

  2019cites this paper
• Involvement of STAT3 Signaling in High Glucose-Induced Epithelial Mesenchymal Transition in Human Peritoneal Mesothelial Cell Line HMrSV5

  2019cites this paper
• Didymin, a dietary citrus flavonoid exhibits anti-diabetic complications and promotes glucose uptake through the activation of PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.

  2019cites this paper
• Histamine and diabetic nephropathy: an up-to-date overview.

  2019cites this paper
• TGF-β/Smad and Renal Fibrosis.

  2019cites this paper
• Nuclear Expression and DNA Binding Capacity of Receptor for Advanced Glycation End Products in Renal Tissue

  2019cites this paper
• A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy.

  2019cites this paper
• Inhibition of TGF-β1 Signaling by IL-15: A Novel Role for IL-15 in the Control of Renal Epithelial-Mesenchymal Transition: IL-15 Counteracts TGF-β1-Induced EMT in Renal Fibrosis

  2019cites this paper
• Alpha-lipoic acid suppresses Nε-(carboxymethyl) lysine-induced epithelial mesenchymal transition in HK-2 human renal proximal tubule cells

  2018cites this paper
• Targeting inflammation in diabetic nephropathy: a tale of hope

  2018cites this paper
• THE EXTRACT SOYBEAN OF LOCAL VARIETIES AS REDUCE ADVANCED GLYCATION END PRODUCTS AND HEMOGLOBIN A1C IN TYPE 2 DIABETES MICE

  2018cites this paper
• Renal tubules transcriptome reveals metabolic maladaption during the progression of ischemia-induced acute kidney injury.

  2018cites this paper
• The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality.

  2018cites this paper
• Metabolic Karma—The Atherogenic Legacy of Diabetes: The 2017 Edwin Bierman Award Lecture

  2018cites this paper
• Identification of pyridinoline, a collagen crosslink, as a novel intrinsic ligand for the receptor for advanced glycation end-products (RAGE)

  2018cites this paper